NEW AMBRX BIOPHARMA INC (AMAM) Stock Income Statement
NASDAQ:AMAM - Nasdaq - US6418711080 - Common Stock - Currency: USD
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.68M | 7.40M | 7.46M | 13.67M | 10.31M | |||
| Minority Interest Expense | N/A | 0.00 | 210.00K | 1.30M | 2.25M | |||
| Operating Expenses | 94.01M | 74.14M | 71.88M | 26.79M | 32.78M | |||
| Research and Development | 57.11M | 31.25M | 53.61M | 19.19M | 25.14M | |||
| Selling, General, and Administrative Expenses | 36.91M | 42.90M | 18.27M | 7.60M | 7.64M | |||
| Operating Income | -88.32M | -66.74M | -64.42M | -13.12M | -22.47M | |||
| Interest Income/Expense | 6.22M | 370.00K | -3.90M | 30.00K | 200.00K | |||
| Other Income/Expense | 230.00K | -30.00K | 40.00K | -4.75M | -40.00K | |||
| Non Recurring Items | 0.00 | -9.66M | N/A | N/A | N/A | |||
| Income Before Taxes | -81.88M | -76.06M | -68.29M | -17.84M | -22.32M | |||
| Income Tax | 750.00K | 1.94M | 0.00 | 0.00 | 0.00 | |||
| Net Income | -82.63M | -78.00M | -68.08M | -16.54M | -20.06M | |||
| EBITDA | -86.52M | -64.94M | -62.27M | -11.18M | -20.42M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.57 | -0.29 | -0.25 | -0.06 | -0.08 | |||
| Statistics | ||||||||
| Profit Margin | -1454.75% | -1054.05% | -912.60% | -120.99% | -194.57% | |||
| Operating Profit Margin | -1554.93% | -901.89% | -863.54% | -95.98% | -217.94% | |||
All data in USD